The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Efficacy of palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients with stomach cancer receiving FOLFOX4 regimen.
S. K. Kim
No relevant relationships to disclose
Y. J. Choi
No relevant relationships to disclose
Y. M. Seol
No relevant relationships to disclose
M. G. Song
No relevant relationships to disclose
H. J. Shin
No relevant relationships to disclose
J. Chung
No relevant relationships to disclose
G. J. Cho
No relevant relationships to disclose